140 related articles for article (PubMed ID: 8486430)
1. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens.
Závada J; Závadová Z; Pastoreková S; Ciampor F; Pastorek J; Zelník V
Int J Cancer; 1993 May; 54(2):268-74. PubMed ID: 8486430
[TBL] [Abstract][Full Text] [Related]
2. A novel quasi-viral agent, MaTu, is a two-component system.
Pastoreková S; Závadová Z; Kostál M; Babusíková O; Závada J
Virology; 1992 Apr; 187(2):620-6. PubMed ID: 1312272
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytic choriomeningitis virus mx strain does not induce the expression of tumor-associated carbonic anhydrase IX in persistently infected HeLa cells.
Labudová M; Tomásková J; Kaluzová M; Pastorek J; Pastoreková S
Acta Virol; 2006; 50(1):53-8. PubMed ID: 16599186
[TBL] [Abstract][Full Text] [Related]
4. Examination of the oncogenic potential of H19 gene in HeLa x normal human fibroblast hybrid cells.
Tsujimoto H; Nishizuka S; Redpath LJ; Stanbridge EJ
Int J Oncol; 2001 Jul; 19(1):89-95. PubMed ID: 11408927
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression in tumorigenic and nontumorigenic HeLa x normal human fibroblast hybrid cells.
Tsujimoto H; Nishizuka S; Redpath JL; Stanbridge EJ
Mol Carcinog; 1999 Dec; 26(4):298-304. PubMed ID: 10569806
[TBL] [Abstract][Full Text] [Related]
6. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids.
Latham KM; Stanbridge EJ
Cancer Res; 1992 Feb; 52(3):616-22. PubMed ID: 1732049
[TBL] [Abstract][Full Text] [Related]
7. Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids.
Mendonca MS; Antoniono RJ; Latham KM; Stanbridge EJ; Redpath JL
Cancer Res; 1991 Aug; 51(16):4455-62. PubMed ID: 1868467
[TBL] [Abstract][Full Text] [Related]
8. An unusual transmissible agent--MaTu.
Závada J; Závadová Z
Arch Virol; 1991; 118(3-4):189-97. PubMed ID: 1648895
[TBL] [Abstract][Full Text] [Related]
9. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.
McKiernan JM; Buttyan R; Bander NH; Stifelman MD; Katz AE; Chen MW; Olsson CA; Sawczuk IS
Cancer Res; 1997 Jun; 57(12):2362-5. PubMed ID: 9192809
[TBL] [Abstract][Full Text] [Related]
10. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
11. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
[TBL] [Abstract][Full Text] [Related]
13. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody.
Chrastina A; Pastoreková S; Pastorek J
Neoplasma; 2003; 50(1):13-21. PubMed ID: 12687273
[TBL] [Abstract][Full Text] [Related]
14. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.
Pastorek J; Pastoreková S; Callebaut I; Mornon JP; Zelník V; Opavský R; Zat'ovicová M; Liao S; Portetelle D; Stanbridge EJ
Oncogene; 1994 Oct; 9(10):2877-88. PubMed ID: 8084592
[TBL] [Abstract][Full Text] [Related]
15. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN.
Brewer CA; Liao SY; Wilczynski SP; Pastorekova S; Pastorek J; Zavada J; Kurosaki T; Manetta A; Berman ML; DiSaia PJ; Stanbridge EJ
Gynecol Oncol; 1996 Dec; 63(3):337-44. PubMed ID: 8946869
[TBL] [Abstract][Full Text] [Related]
16. Selective incorporation of fibronectin isoforms into the extracellular matrix of hybrids between human fibrosarcoma cells and normal human fibroblasts.
Devlin J; Harris H
Exp Cell Res; 1994 Sep; 214(1):429-32. PubMed ID: 8082745
[TBL] [Abstract][Full Text] [Related]
17. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
18. Identification of the HeLa tumor-associated antigen, p75/150, as intestinal alkaline phosphatase and evidence for its transcriptional regulation.
Latham KM; Stanbridge EJ
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1263-7. PubMed ID: 2304898
[TBL] [Abstract][Full Text] [Related]
19. High cell density-mediated pericellular hypoxia is a crucial factor inducing expression of the intrinsic hypoxia marker CA IX in vitro in HeLa cells.
Chrastina A
Neoplasma; 2003; 50(4):251-6. PubMed ID: 12937836
[TBL] [Abstract][Full Text] [Related]
20. Restored gap junctional communication in non-tumorigenic HeLa-normal human fibroblast hybrids.
de Feijter-Rupp HL; Hayashi T; Kalimi GH; Edwards P; Redpath JL; Chang CC; Stanbridge EJ; Trosko JE
Carcinogenesis; 1998 May; 19(5):747-54. PubMed ID: 9635859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
